SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection | BMJ Open
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Therapeutics Initiative | How do you prescribe ACEIs and ARBs for hypertension?
ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients - Zhao - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
ACE Inhibitors - almostadoctor
Nutrients | Free Full-Text | ACEI-Inhibitory Peptides Naturally Generated in Meat and Meat Products and Their Health Relevance
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
Side Effects of ACEi/ARBs During Pregnancy | Calgary Guide
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Cureus | Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study | Article
Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis | PLOS Computational Biology
RACGP - ACEIs for cardiovascular risk reduction – have we taken our eye off the ball?
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials | BMC Cardiovascular Disorders | Full Text
ACE inhibitor - Wikipedia
Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea | Scientific Reports
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
Angiotensin inhibition in patients with acute kidney injury: Dr. Jekyll or Mr. Hyde? | SpringerLink
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
RACGP - ACEIs for cardiovascular risk reduction – have we taken our eye off the ball?
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB | SpringerLink
Renin - Angiotenisn inhibitors: ACEi, ARB and Aliskerin. - YouTube
Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease - Larouche‐Lebel - 2021 - Journal of Veterinary Internal Medicine - Wiley Online Library
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
